FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kakisis, JD
AF Kakisis, John D.
TI Saffron: From Greek mythology to contemporary anti-atherosclerotic
   medicine
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Atherosclerosis; Inflammation; Saffron; Crocetin; Crocus sativus
ID VIRGIN OLIVE OIL; RED WINE; INFLAMMATORY BIOMARKERS; ATHEROSCLEROTIC
   PLAQUE; CONSUMPTION; EXPRESSION
C1 [Kakisis, John D.] Univ Athens, Sch Med, Attikon Hosp, Dept Vasc Surg, Athens, Greece.
RP Kakisis, JD (reprint author), Univ Athens, Sch Med, Attikon Hosp, Dept Vasc Surg, Athens, Greece.
EM kakisis@med.uoa.gr
NR 20
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 193
EP 195
DI 10.1016/j.atherosclerosis.2017.11.021
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500028
PM 29198557
DA 2019-10-28
ER

PT J
AU Xu, YX
   Redon, V
   Yu, HJ
   Querbes, W
   Pirruccello, J
   Liebow, A
   Deik, A
   Trindade, K
   Wang, X
   Musunuru, K
   Clish, CB
   Cowan, C
   Fizgerald, K
   Rader, D
   Kathiresan, S
AF Xu, Yu-Xin
   Redon, Valeska
   Yu, Haojie
   Querbes, William
   Pirruccello, James
   Liebow, Abigail
   Deik, Amy
   Trindade, Kevin
   Wang, Xiao
   Musunuru, Kiran
   Clish, Clary B.
   Cowan, Chad
   Fizgerald, Kevin
   Rader, Daniel
   Kathiresan, Sekar
TI Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of
   low-density lipoprotein cholesterol
SO ATHEROSCLEROSIS
LA English
DT Article
DE Angiopoietin-like protein 3; ANGPTL3; Lipoprotein; LDL receptor; LDLR;
   Low-density lipoprotein; LDL; High-density lipoprotein; HDL;
   Triglycerides; Cholesterol
ID ESTER TRANSFER PROTEIN; CORONARY-ARTERY-DISEASE; ENDOTHELIAL LIPASE;
   APOLIPOPROTEIN-B; LIPID-METABOLISM; TRANSGENIC MICE; IN-VIVO;
   INACTIVATION; INHIBITION; RISK
AB Background and aims: Angiopoietin-like 3 (ANGPTL3) has emerged as a key regulator of lipoprotein metabolism in humans. Homozygous loss of ANGPTL3 function causes familial combined hypolipidemia characterized by low plasma levels of triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C). While known effects of ANGPTL3 in inhibiting lipoprotein lipase and endothelial lipase contribute to the low TG and HDL-C, respectively, the basis of low LDL-C remains unclear. Our aim was to explore the role of ANGPTL3 in modulating plasma LDL-C.
   Methods: We performed RNAi-mediated gene silencing of ANGPTL3 in five mouse models and in human hepatoma cells. We validated results by deleting ANGPTL3 gene using the CRISPR/Cas9 genome editing system.
   Results: RNAi-mediated Angptl3 silencing in mouse livers resulted in very low TG, HDL-C and LDL-C, a pattern similar to the human phenotype. The effect was observed in wild-type and obese mice, while in hCETP/apolipoprotein (Apo) B-100 double transgenic mice, the silencing decreased LDL-C and TG, but not HDL-C. In a humanized mouse model (Apobec1(-/-) carrying human ApoB-100 transgene) deficient in the LDL receptor (LDLR), Angptl3 silencing had minimum effect on LDL-C, suggesting the effect being linked to LDLR. This observation is supported by an additive effect on LDL-C between ANGPTL3 and PCSK9 siRNAs. ANGPTL3 gene deletion induced cellular long-chain TG and ApoB-100 accumulation with elevated LDLR and LDLR-related protein (LRP) 1 expression. Consistent with this, ANGPTL3 deficiency by gene deletion or silencing reduced nascent ApoB-100 secretion and increased LDL/VLDL uptake.
   Conclusions: Reduced secretion and increased uptake of ApoB-containing lipoproteins may contribute to the low LDL-C observed in mice and humans with genetic ANGPTL3 deficiency. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Xu, Yu-Xin; Pirruccello, James; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Simches 5-830,185 Cambridge St, Boston, MA 02114 USA.
   [Redon, Valeska; Trindade, Kevin; Rader, Daniel] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, 11-125 Translat Res Ctr,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.
   [Yu, Haojie; Cowan, Chad] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Querbes, William; Liebow, Abigail; Fizgerald, Kevin] Alnylam Pharmaceut, 300 Third St,3rd Floor, Cambridge, MA 02142 USA.
   [Deik, Amy; Clish, Clary B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.
   [Wang, Xiao; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Dept Med, Philadelphia, PA 19104 USA.
   [Cowan, Chad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   [Pirruccello, James] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.
RP Kathiresan, S (reprint author), Massachusetts Gen Hosp, Ctr Genom Med, Simches 5-830,185 Cambridge St, Boston, MA 02114 USA.; Kathiresan, S (reprint author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Simches 5-830,185 Cambridge St, Boston, MA 02114 USA.
EM skathiresan1@partners.org
RI Clish, Clary/AAB-7124-2019
OI Clish, Clary/0000-0001-8259-9245
FU National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R37-HL055323,
   RC2-HL101864, R33-HL120781]; Ofer and Shelly Nemirovsky Research Scholar
   award from the Massachusetts General Hospital (MGH); Howard Goodman
   Fellowship from MGH; Donovan Family Foundation; Foundation LeducqLeducq
   Foundation [12-CDA-04]; American Heart Association SDG grantAmerican
   Heart Association [11SDG7670007]
FX This work was supported in part by the National Heart, Lung, and Blood
   Institute (R37-HL055323 and RC2-HL101864 to DJR; R33-HL120781 to SK and
   CC). SK is supported by the Ofer and Shelly Nemirovsky Research Scholar
   award from the Massachusetts General Hospital (MGH), the Howard Goodman
   Fellowship from MGH, the Donovan Family Foundation and a grant from
   Foundation Leducq (12-CDA-04). YXX was in part supported by American
   Heart Association SDG grant (11SDG7670007) (2011-2015).
NR 35
TC 18
Z9 19
U1 1
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 196
EP 206
DI 10.1016/j.atherosclerosis.2017.08.031
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500029
PM 29183623
OA Green Accepted
DA 2019-10-28
ER

PT J
AU Wang, SB
   Mitchell, P
   Liew, G
   Wong, TY
   Phan, K
   Thiagalingam, A
   Joachim, N
   Burlutsky, G
   Gopinath, B
AF Wang, Sarah B.
   Mitchell, Paul
   Liew, Gerald
   Wong, Tien Yin
   Phan, Kevin
   Thiagalingam, Aravinda
   Joachim, Nichole
   Burlutsky, George
   Gopinath, Bamini
TI A spectrum of retinal vasculature measures and coronary artery disease
SO ATHEROSCLEROSIS
LA English
DT Article
DE Fractal dimension; Retinal microvasculature; Retinal vessel calibre;
   Coronary artery disease; Gensini score; Extent score; Australian heart
   eye study
ID JOINT NATIONAL COMMITTEE; FRACTAL ANALYSIS; HEART-DISEASE; MICROVASCULAR
   STRUCTURE; ATHEROSCLEROSIS RISK; ANGINA-PECTORIS; VESSEL DIAMETER;
   BLOOD-PRESSURE; IMAGE-ANALYSIS; 7TH REPORT
AB Background and aims: We aimed to comprehensively describe a spectrum of retinal vessel measures including fractal dimension (D-f) and their associations with indices of coronary artery disease (CAD) extent and severity, as well as hypertension and diabetes.
   Methods: The Australian Heart Eye Study (AHES) is an observational study that surveyed 1680 participants presenting to a tertiary referral hospital for the evaluation of potential CAD by coronary angiography. A range of newer retinal vessel geometric measures (D-f, curvature tortuosity, and branching angle) were quantified from retinal photographs using semi-automated software, the Singapore 'I' Vessel Assessment (SIVA) tool. A combined retinal score was constructed, aiming to assess the joint effect of multiple retinal vessel parameters on CAD, comprising of those variables that were most strongly significant in multivariate analysis - D-f, arteriolar curvature tortuosity, and retinal arteriolar calibre. CAD was objectively quantified using a range of measures obtained from coronary angiography.
   Results: A total of 1187 participants had complete data on retinal vessel measurements and coronary vessel evaluation. Retinal vascular D-f and curvature tortuosity decreased with increasing age; women had significantly lower D-f than men (p<0.003). Straighter retinal vessels were associated with CAD extent and Gensini scores in multivariable analysis (p<0.02). Accounting for media opacity by sub-group analysis in pseudophakic patients, the combined retinal score was associated with stenosis greater than 50% in any coronary artery segment (vessel score) and obstructive coronary stenosis in all three main coronary arteries (segment score) (p = 0.01). Lower Df and narrower arteriolar branching angle were associated with CAD vessel score (p<0.03). In sex-stratified multivariate analyses, straighter arterioles were associated with greater odds of CAD in men, and narrower venular branching angle was associated with CAD in women.
   Conclusions: A range of retinal vessel measures were associated with CAD extent and severity. A sparser retinal microvascular network (smaller D-f) was associated with older age and female gender. After accounting for the impact of media opacity, retinal vessel measures were associated with more diffuse and severe CAD. (c) 2017 Elsevier B.V. All rights reserved.
C1 [Wang, Sarah B.; Mitchell, Paul; Liew, Gerald; Joachim, Nichole; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Hawkesbury Rd, Westmead, NSW 2145, Australia.
   [Phan, Kevin; Thiagalingam, Aravinda] Univ Sydney, Westmead Inst Med Res, Ctr Heart Res, Westmead, NSW, Australia.
   [Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.
RP Gopinath, B (reprint author), Univ Sydney, Westmead Inst Med Res, Ctr Vis Res, Hawkesbury Rd, Westmead, NSW 2145, Australia.
EM bamini.gopinath@sydney.edu.au
RI Gopinath, Bamini/K-4286-2019
OI Gopinath, Bamini/0000-0003-3573-359X
NR 77
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 215
EP 224
DI 10.1016/j.atherosclerosis.2017.10.008
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500031
PM 29050745
DA 2019-10-28
ER

PT J
AU Ashrafi-Asgarabad, A
   Safiri, S
AF Ashrafi-Asgarabad, Ahad
   Safiri, Saeid
TI Prognostic value of lipoprotein-associated phospholipase A2 mass for
   all-cause mortality and vascular events within one year after acute
   ischemic stroke: Methodological issues
SO ATHEROSCLEROSIS
LA English
DT Letter
DE Lp-PLA2 mass; All-cause mortality; Vascular events; Acute ischemic
   stroke; Prognosis; Methodology
C1 [Ashrafi-Asgarabad, Ahad] Shahid Beheshti Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran.
   [Ashrafi-Asgarabad, Ahad] Bam Univ Med Sci, Dept Epidemiol, Bam, Iran.
   [Safiri, Saeid] Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran.
   [Safiri, Saeid] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.
RP Safiri, S (reprint author), Maragheh Univ Med Sci, Sch Nursing & Midwifery, Dept Publ Hlth, Managerial Epidemiol Res Ctr, Maragheh, Iran.
EM saeidsafiri@gmail.com
NR 5
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 231
EP 232
DI 10.1016/j.atherosclerosis.2017.10.021
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500033
PM 29102657
DA 2019-10-28
ER

PT J
AU Zhong, CK
   Han, LY
   Zhang, YH
AF Zhong, Chongke
   Han, Liyuan
   Zhang, Yonghong
TI Reply to: "Prognostic value of lipoprotein-associated phospholipase A2
   mass for all-cause mortality and vascular events within one year after
   acute ischemic stroke: Methodological issues"
SO ATHEROSCLEROSIS
LA English
DT Letter
DE Lp-PLA2 mass; Mortality; Acute ischemic stroke; Prognosis
ID GLOMERULAR-FILTRATION-RATE; OUTCOMES
C1 [Zhong, Chongke; Han, Liyuan; Zhang, Yonghong] Soochow Univ, Med Coll, Sch Publ Hlth, Dept Epidemiol, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhong, Chongke; Han, Liyuan; Zhang, Yonghong] Soochow Univ, Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhong, Chongke; Han, Liyuan; Zhang, Yonghong] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
   [Han, Liyuan] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Dept Prevent Med, Ningbo, Zhejiang, Peoples R China.
RP Zhang, YH (reprint author), Soochow Univ, Med Coll, Sch Publ Hlth, Dept Epidemiol, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, YH (reprint author), Soochow Univ, Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.
EM yhzhang@suda.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81320108026]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [156458]; Jiangsu
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [1601121B]; Natural Science Foundation of Zhejiang ProvinceNatural
   Science Foundation of Zhejiang Province [LY17H260002]; National Natural
   Science Foundation of Ningbo [2017A610219]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions, China; Tulane
   University in New Orleans, Louisiana; Collins C. Diboll Private
   Foundation in New Orleans, Louisiana
FX This study was supported by the National Natural Science Foundation of
   China (grants: 81320108026), China Postdoctoral Science Foundation
   funded project (156458), Jiangsu Postdoctoral Science Foundation funded
   project (1601121B), Natural Science Foundation of Zhejiang Province
   (LY17H260002), National Natural Science Foundation of Ningbo
   (2017A610219) and a Project of the Priority Academic Program Development
   of Jiangsu Higher Education Institutions, China; Tulane University and
   Collins C. Diboll Private Foundation, both in New Orleans, Louisiana.
NR 5
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 233
EP 234
DI 10.1016/j.atherosclerosis.2017.11.013
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500034
PM 29174392
DA 2019-10-28
ER

PT J
AU Tang, ZH
   Liu, LS
   Zheng, XL
   Jiang, ZS
AF Tang, Zhi-Han
   Liu, Lu-Shan
   Zheng, Xi-Long
   Jiang, Zhi-Sheng
TI Reply to: "PCSK9 antagonists and inflammation"
SO ATHEROSCLEROSIS
LA English
DT Letter
DE PCSK9; Inflammation; PCSK9 inhibitors; Atherosclerotic cardiovascular
   disease
ID HIGH CARDIOVASCULAR RISK; ATHEROSCLEROSIS; EXPRESSION; CHOLESTEROL;
   ALIROCUMAB; FIBRINOGEN; RESISTIN; EFFICACY; SAFETY
C1 [Tang, Zhi-Han; Liu, Lu-Shan; Jiang, Zhi-Sheng] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China.
   [Zheng, Xi-Long] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Hlth Sci Ctr, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
RP Jiang, ZS (reprint author), Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China.
EM zsjiang2005@163.com
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD JAN
PY 2018
VL 268
BP 237
EP 238
DI 10.1016/j.atherosclerosis.2017.11.014
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FR5IF
UT WOS:000419099500036
PM 29174393
DA 2019-10-28
ER

EF